While first-responders celebrated the news two years ago that Sept. 11-related cancer care would be covered by the Federal government under the Zadroga Act, another less-recognized ailment appears to have been quietly stalking some survivors.
Dr. Mary Ann McLaughlin, a researcher at Mt. Sinai’s Icahn School of Medicine, was at the time leading a study that would link inhalation of toxic 9/11 dust to kidney disease.
This item is available in full to subscribers.
We have recently launched a new and improved website. To continue reading, you will need to either log into your subscriber account, or purchase a new subscription.
If you have an active digital subscription, then you already have an account here. Just reset your password, if you've not yet logged in to your account on this new site.
If you are a current print-only subscriber, and want access to our website,click here to view your options for changing you subscription level.
Otherwise, click here to view your options for subscribing.
Please log in to continue |
